GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer

INTRODUCTION: Tamoxifen is widely used to treat hormone-dependent breast cancer, but its therapeutic benefit is limited by the development of drug resistance. Here, we investigated the role of estrogen G-protein coupled receptor 30 (GPR30) on Tamoxifen resistance in breast cancer. METHODS: Primary t...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Mo, Zhiqiang, Liu, Manran, Yang, Fangfang, Luo, Haojun, Li, Zhenhua, Tu, Gang, Yang, Guanglun
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2013
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978564/
https://ncbi.nlm.nih.gov/pubmed/24289103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3581
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg